CoChat

Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study

Open access
Crabtree, Thomas S.J., Griffin, Tomás P., Yap, Yew W., Narendran, Parth, Gallen, Geraldine, Furlong, Niall, Cranston, Iain, Chakera, Ali, Philbey, Chris, Karamat, Muhammad Ali, Saraf, Sanjay, Kamaruddin, Shafie, Gurnell, Eleanor, Chapman, Alyson, Hussain, Sufyan, Elliott, Jackie, Leelarathna, Lalantha, Ryder, Robert E.J., Hammond, Peter, Lumb, Alistair, Choudhary, Pratik, Wilmot, Emma G., The ABCD Closed-Loop Audit Contributors, Evans, Mark, Gurnell, Eleanor, Hartnell, Sara, Davenport, Katy, O’Reilly, Iona, Brown, Helen, Kamaruddin, Shafie, Pickering, Sharon, Abouglia, Kamal, Wadham, Claire, Rayman, Gerry, Hussain, Sufyan, Brackenridge, Anna, Pender, Siobhan, Atkinson, Rosarie, Bahadur, Melanie, Eid, Hatem, Carling, Janet, Oldfield, Linzi, Philbey, Christopher, Hammond, Peter, Haywood, Sean, Gallen, Geraldine, Rodgers, Helen, Lovie, Kaylee, Whight, Emma, Nobel-Bell, Georgia, Harris, Sophie, Cartwright, Anne, Garnett, Ian, Harvey, Jennifer, McCulloch, Frances, Yap, Yew Wen, Weston, Philip, Chapman, Alyson, Findlow, Lynne, Leelarathna, Lalantha, Ohol, Sheetal, Thabit, Hood, Urwin, Andrea, Cowlam, Darron, Thomas, Sonia, Hyland, Emma, Yearsley, Zoey, Schofield, Johnathan, Soar, Clare, Fenn, Laura, Mendis, Budd, Htike, Zin Zin, Cheyne, Elizabeth, Emsley, Julie, Jones, Elisabeth, Parfitt, Vernon, Sawyer, Lynn, Colosimo, Santo, Apsara, Shani, Mathara Diddhenipothage, Dilrukshi, Lumb, Alistar, Hards, Katie, Edohen, Florence, Beaden, Sue, Cranston, Iain, Taylor, Julie, Skinner, Lisa, Bawlchhim, Zosanglura, Tuthill, Bev, Cull, Melissa Louise, Ryder, Robert E.J., Mitchell, Sarah, Rimell, Jill, Foley, Clare, Gianfrancesco, Carla, Elliott, Jackie, Butter, Sally, Carrieri, Giorgio, Douek, Isy, King, Rhodri, Lambert, Paul, Lionetti, Paula, Cardwell, Janet, Furlong, Niall, Keigan, Suzanne, Milne, Rachael, Wilkinson, Philomena, Ashton-Cleary, Siobhan, White, Sarah, Anthony, Karen, Ribul Mazzola, Stefania, Sweeney, Stephanie, Narendran, Parth, Karamat, Ali, Saraf, Sanjay, Hudson, Barbara, Li, Manyee, Skelding, Rebecca, Williams, Lisa, Bartha, Karen, Jesson, Anna-Marie, Grandy, Lynn, Brewer, Deborah, Edwards, Joanne, Sears, Nicola, Shergil, Manjit, Baldwin, Andy, Crabtree, Thomas, Van Heeswijk, Isabelle, Langeland, Linn, Taylor, Nicola, Wilmot, Emma, Owen, Sarah, Taylor, Rachel, Robinson, Emma, Bakhit, Mohammed, Redfern, Amy, Kedge, Cathy, Kotonya, Christine, Hayat, Haleema, Gerrard, Katy, Pearson, Nicci, Redfern, Zara, Curtis, Louise, Galea, Alison, Weiss, Melanie, Stacey, Nikki, Partridge, Helen, Choudhary, Pratik, Griffin, Tomás, Ackroyd, Dawn, Turrell, Liz, Chakera, Ali J., Lambert, Vicki, Suarez, Alison, Kirby, Jesina, Lloyd, Nicola, Karathenasi, Eleni, McKinnon, Samantha, Levitt, Mindy, Govindan, Raj, Haskoll, Becky, Saunders, Simon, Kehinde, Razak, Lee, James, Galliford, Thomas, Bickerton, Alex, Hammond, Ruth, Walker, Ruth · 2023 · Diabetes Care
Cited by 88

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: We explored longitudinal changes associated with switching to hybrid closed-loop (HCL) insulin delivery systems in adults with type 1 diabetes and elevated HbA1c levels despite the use of intermittently scanned continuous glucose monitoring (isCGM) and insulin pump therapy. RESEARCH DESIGN AND METHODS: We undertook a pragmatic, preplanned observational study of participants included in the National Health Service England closed-loop pilot. Adults using isCGM and insulin pump across 31 diabetes centers in England with an HbA1c ≥8.5% who were willing to commence HCL therapy were included. Outcomes included change in HbA1c, sensor glucometrics, diabetes distress score, Gold score (hypoglycemia awareness), acute event rates, and user opinion of HCL. RESULTS: In total, 570 HCL users were included (median age 40 [IQR 29–50] years, 67% female, and 85% White). Mean baseline HbA1c was 9.4 ± 0.9% (78.9 ± 9.1 mmol/mol) with a median follow-up of 5.1 (IQR 3.9–6.6) months. Of 520 users continuing HCL at follow-up, mean adjusted HbA1c reduced by 1.7% (95% CI 1.5, 1.8; P < 0.0001) (18.1 mmol/mol [95% CI 16.6, 19.6]; P < 0.0001). Time in range (70–180 mg/dL) increased from 34.2 to 61.9% (P < 0.001). Individuals with HbA1c of ≤58 mmol/mol rose from 0 to 39.4% (P < 0.0001), and those achieving ≥70% glucose time in range and <4% time below range increased from 0.8 to 28.2% (P < 0.0001). Almost all participants rated HCL therapy as having a positive impact on quality of life (94.7% [540 of 570]). CONCLUSIONS: Use of HCL is associated with improvements in HbA1c, time in range, hypoglycemia, and diabetes-related distress and quality of life in people with type 1 diabetes in the real world.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc23-0635

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

Metadata

Authors
Crabtree, T. S. J., Griffin, T. P., Yap, Y. W., Narendran, P., Gallen, G., Furlong, N., Cranston, I., Chakera, A., Philbey, C., Karamat, M. A., Saraf, S., Kamaruddin, S., Gurnell, E., Chapman, A., Hussain, S., Elliott, J., Leelarathna, L., Ryder, R. E. J., Hammond, P., Lumb, A., Choudhary, P., Wilmot, E. G., Contributors, T. A. C.-L. A., Evans, M., Gurnell, E., Hartnell, S., Davenport, K., O’Reilly, I., Brown, H., Kamaruddin, S., Pickering, S., Abouglia, K., Wadham, C., Rayman, G., Hussain, S., Brackenridge, A., Pender, S., Atkinson, R., Bahadur, M., Eid, H., Carling, J., Oldfield, L., Philbey, C., Hammond, P., Haywood, S., Gallen, G., Rodgers, H., Lovie, K., Whight, E., Nobel-Bell, G., Harris, S., Cartwright, A., Garnett, I., Harvey, J., McCulloch, F., Yap, Y. W., Weston, P., Chapman, A., Findlow, L., Leelarathna, L., Ohol, S., Thabit, H., Urwin, A., Cowlam, D., Thomas, S., Hyland, E., Yearsley, Z., Schofield, J., Soar, C., Fenn, L., Mendis, B., Htike, Z. Z., Cheyne, E., Emsley, J., Jones, E., Parfitt, V., Sawyer, L., Colosimo, S., Apsara, S., Mathara Diddhenipothage, D., Lumb, A., Hards, K., Edohen, F., Beaden, S., Cranston, I., Taylor, J., Skinner, L., Bawlchhim, Z., Tuthill, B., Cull, M. L., Ryder, R. E. J., Mitchell, S., Rimell, J., Foley, C., Gianfrancesco, C., Elliott, J., Butter, S., Carrieri, G., Douek, I., King, R., Lambert, P., Lionetti, P., Cardwell, J., Furlong, N., Keigan, S., Milne, R., Wilkinson, P., Ashton-Cleary, S., White, S., Anthony, K., Ribul Mazzola, S., Sweeney, S., Narendran, P., Karamat, A., Saraf, S., Hudson, B., Li, M., Skelding, R., Williams, L., Bartha, K., Jesson, A.-M., Grandy, L., Brewer, D., Edwards, J., Sears, N., Shergil, M., Baldwin, A., Crabtree, T., Van Heeswijk, I., Langeland, L., Taylor, N., Wilmot, E., Owen, S., Taylor, R., Robinson, E., Bakhit, M., Redfern, A., Kedge, C., Kotonya, C., Hayat, H., Gerrard, K., Pearson, N., Redfern, Z., Curtis, L., Galea, A., Weiss, M., Stacey, N., Partridge, H., Choudhary, P., Griffin, T., Ackroyd, D., Turrell, L., Chakera, A. J., Lambert, V., Suarez, A., Kirby, J., Lloyd, N., Karathenasi, E., McKinnon, S., Levitt, M., Govindan, R., Haskoll, B., Saunders, S., Kehinde, R., Lee, J., Galliford, T., Bickerton, A., Hammond, R., & Walker, R.
Venue
Diabetes Care
Published
2023-08-11
Volume
46
Issue
10
Pages
1831-1838
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W4385754731
Cited by
88
References
15
FWCI
14.56
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.